North America Hydrocephalus Shunts Market

The North America hydrocephalus shunts market is expected to grow from US$ 122.61 million in 2022 to US$ 150.64 million by 2028. It is estimated to record a CAGR of 3.5% from 2022 to 2028.

Increasing Prevalence of Hydrocephalus Bolsters North America Hydrocephalus Shunts Market Growth

Cerebrospinal fluid (CSF) in the brain and spinal cord protects the central nervous system from injuries and infections. The accumulation of excess CSF in brain cavities adds to intracranial pressure, thereby leading to hydrocephalus. The condition may further lead to macrocephaly and cognitive dysfunctions. Hydrocephalus is more prevalent in children and infants than in the adult population. The disease is also prevalent in people aged 60 and above. According to the Hydrocephalus Association, the disease affects over 1 million Americans. Additionally, the incidence rate of hydrocephalus in the US is 1 in every 770 babies. The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus drives the demand for hydrocephalus shunts, thereby boosting the North America hydrocephalus shunts market growth.

Market Overview

The North America hydrocephalus shunts market has been segmented into the US, Canada, and Mexico. The US is the key contributor to the market in this region. The market growth in this region is attributed to the rise in health concerns with increasing neurological disease incidence and the availability of a well-developed healthcare structure. According to the Hydrocephalus Organization, hydrocephalus is a neurological disorder that affects 1 out of 770 new-born and 1 out of 100 senior citizens in America. Furthermore, high investments by key medical companies in the R&D of neurosurgical devices to lower the socioeconomic burden of hydrocephalus boost the market growth in North America.

North America Hydrocephalus Shunts Market  Revenue and Forecast to 2028 (US$ Million)

North America Hydrocephalus Shunts Strategic Insights

Strategic insights for the North America Hydrocephalus Shunts provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Hydrocephalus Shunts Report Scope

North America Hydrocephalus Shunts Regional Insights

The geographic scope of the North America Hydrocephalus Shunts refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Hydrocephalus Shunts Market Segmentation 

The North America hydrocephalus shunts market is segmented on the basis of age group, type, product, end user and country.

Based on age group, the North America hydrocephalus shunts market is bifurcated into pediatric and adults. The pediatric segment is expected to hold a larger market share in 2022.

In terms of type, the North America hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment would hold the largest market share in 2022.

The North America hydrocephalus shunts market, by product, is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment is expected to dominate the market in 2022.

Based on end user, the North America hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is likely to dominate the market in 2022.

In terms of country, the North America hydrocephalus shunts market is segmented into US, Canada, and Mexico. The US is expected to dominate the market in 2022.

B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Próteses, inc. ; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG. are the leading companies operating in the North America hydrocephalus shunts market.